Myc and Max proteins possess distinct transcriptional activities

[1]  M. Cole,et al.  Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/Max heterodimers. , 1992, Genes & development.

[2]  M. Schwab,et al.  The N‐Myc oncoprotein is associated in vivo with the phosphoprotein Max(p20/22) in human neuroblastoma cells. , 1991, The EMBO journal.

[3]  A. Rustgi,et al.  Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product , 1991, Nature.

[4]  T. Halazonetis,et al.  Determination of the c-MYC DNA-binding site. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[5]  G. Prendergast,et al.  Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation , 1991, Cell.

[6]  J. Moore,et al.  c-myc protein expression in untransformed fibroblasts. , 1991, Oncogene.

[7]  Tony Hunter,et al.  Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity , 1991, Cell.

[8]  H. Weintraub,et al.  Sequence-specific DNA binding by the c-Myc protein. , 1990, Science.

[9]  J. Barrett,et al.  An amino-terminal c-myc domain required for neoplastic transformation activates transcription , 1990, Molecular and cellular biology.

[10]  R. Roeder,et al.  The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer. , 1990, Genes & development.

[11]  W. Wachsman,et al.  Interaction of host cell proteins with the human T-cell leukemia virus type I transcriptional control region. II. A comprehensive map of protein-binding sites facilitates construction of a simple chimeric promoter responsive to the viral tax2 gene product. , 1990, The Journal of biological chemistry.

[12]  Nic Jones,et al.  Transcriptional regulation by dimerization: Two sides to an incestuous relationship , 1990, Cell.

[13]  L. Su,et al.  TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer muE3 motif. , 1990, Genes & development.

[14]  M. Ptashne.  How eukaryotic transcriptional activators work , 1988, Nature.

[15]  A. Geballe,et al.  Translational control of cytomegalovirus gene expression is mediated by upstream AUG codons , 1988, Journal of virology.

[16]  T. Hunter,et al.  The c-fos protein interacts with c-Jun AP-1 to stimulate transcription of AP-1 responsive genes , 1988, Cell.

[17]  J. Greene,et al.  Activation and repression of mammalian gene expression by the c-myc protein. , 1987, Genes & development.

[18]  G. Sonenshein,et al.  Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact. , 1986, The Journal of biological chemistry.

[19]  H. Weintraub,et al.  Translation of mRNA injected into Xenopus oocytes is specifically inhibited by antisense RNA , 1985, The Journal of cell biology.

[20]  P. Sharp,et al.  Transcription Control by Oncogenes , 1985, Cell.

[21]  R. Eisenman,et al.  c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells , 1985, Nature.

[22]  R. Eisenman,et al.  Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells , 1984, Molecular and cellular biology.

[23]  P. Leder,et al.  Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor , 1983, Cell.

[24]  B. Howard,et al.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells , 1982, Molecular and cellular biology.

[25]  R. Eisenman,et al.  Myc and Max associate in vivo. , 1992, Genes & development.

[26]  C. Dang,et al.  Max: functional domains and interaction with c-Myc. , 1992, Genes & development.